NCT04750759View on ClinicalTrials.gov

Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat

PHASE2TerminatedINTERVENTIONAL

Enrollment

4

Participants

Timeline

Start Date

February 3, 2021

Primary Completion Date

October 29, 2021

Study Completion Date

October 29, 2021

Conditions

Covid19

Interventions

DRUG

Niclosamide + Camostat

Niclosamide will be applied in combination with camostat.

OTHER

Placebo

Placebo to interventional drug

Trial Locations (1)

10117

Charité Research Organisation GmbH, Berlin

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Bayer

INDUSTRY

lead

Charité Research Organisation GmbH

OTHER

NCT04750759 - Safety and Preliminary Efficacy of the Combination of Niclosamide and Camostat | Biotech Hunter | Biotech Hunter